SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Specialized Disclosure Report
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction
9001 Spectrum Center Blvd.
San Diego, California 92123
(Address of Principal Executive Offices)
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|x||Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2014|
Section 1 - Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Conflict Minerals Disclosure
This Form SD reports on the period from January 1, 2014 through December 31, 2014.
The description of our reasonable country of origin inquiry (RCOI) process, the results of our inquiry, and the determination we reached as a result of our RCOI process is included in our Conflict Minerals Report attached as an exhibit 1.01 to this Form SD. A copy of the report is available at www.resmed.com > For Investors > Board and Management > Corporate Governance.
Section 2 - Exhibits
Item 2.01 Exhibits
The following exhibit is filed as part of this report.
Exhibit 1.01 Conflict Minerals Report for the reporting period January 1, 2014 to December 31, 2014.
We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.
|Date: May 27, 2015||RESMED INC.|
|Its:||Chief Administrative Officer, global general counsel and secretary|
|1.01||Conflict Minerals Report for the reporting period January 1, 2014 to December 31, 2014.|